Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial

The Lancet Oncology · Published 2026-06-29 · DOI 10.1016/s1470-2045(26)00085-9

Authors (31)

Koen P Rovers, Checca Bakkers, Teun B M van den Heuvel, Vincent C J van de Vlasakker, Teun M E Kerkhoff, Simon W Nienhuijs, Jacobus W A Burger, Geert-Jan M Creemers, Irene E G van Hellemond, Jurriaan B Tuynman, Miranda Kusters, Tineke E Buffart, Arend G J Aalbers, Niels F M Kok, Myriam Chalabi, Djamila Boerma, Alexandra R M Brandt-Kerkhof, Philip R de Reuver, Patrick H J Hemmer, Wilhelmina M U van Grevenstein, Kurt van der Speeten, Petur Snaebjornsson, Pui Yuen Lee-Law, Max J Lahaye, Joost Nederend, Onno Kranenburg, Jeanette M Bouma, Cornelis J A Punt, Marcel G W Dijkgraaf, Pieter J Tanis, Ignace H J T de Hingh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rovers, K., Bakkers, C., Heuvel, T., et al. (2026). Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00085-9

Related articles